---
kind: "section"
citation: "40 C.F.R. § 721.11303"
title: "40"
number: "721.11303"
heading: "2-oxepanone, reaction products with alkylenediamine-alkyleneimine polymer, 2-[[(2-alkyl)oxy]alkyl]oxirane and tetrahydro-2H-pyran-2-one (generic)."
url: "https://uscodex.org/cfr/40/721.11303"
---

# §721.11303. 2-oxepanone, reaction products with alkylenediamine-alkyleneimine polymer, 2-[[(2-alkyl)oxy]alkyl]oxirane and tetrahydro-2H-pyran-2-one (generic).

- (a) **Chemical substance and significant new uses subject to reporting.**
  - (1) The chemical substance identified generically as 2-oxepanone, reaction products with alkylenediamine-alkyleneimine polymer, 2-[[(2-alkyl)oxy]alkyl]oxirane and tetrahydro-2H-pyran-2-one (PMN P-17-220) is subject to reporting under this section for the significant new uses described in [paragraph (a)(2)](#a-2) of this section.
  - (2) **The significant new uses are—**
    - (i) **Industrial, commercial, and consumer activities.** Requirements as specified in § [721.80(f)](/cfr/40/721.80.md?p=f) and [(j)](/cfr/40/721.80.md?p=j). It is a significant new use to manufacture or import the PMN substance other than in liquid form.
    - (ii) [Reserved]
- (b) **Specific requirements.** The provisions of [subpart A](/cfr/40/subpartA.md) of this part apply to this section except as modified by this [paragraph (b)](#b).
  - (1) **Recordkeeping.** Recordkeeping requirements as specified in § [721.125(a) through (c)](/cfr/40/721.125.md?p=a..c) and [(i)](/cfr/40/721.125.md?p=i) are applicable to manufacturers and processors of this substance.
  - (2) **Limitation or revocation of certain notification requirements.** The provisions of [§ 721.185](/cfr/40/721.185.md) apply to this section.
  - (3) **Determining whether a specific use is subject to this section.** The provisions of [§ 721.1725(b)(1)](/cfr/40/721.1725.md?p=b-1) apply to [paragraph (a)(2)(i)](#a-2-i) of this section.

## Notes

### Amendments

[86 FR 46128, Aug. 18, 2021]

### Authority

Authority: 15 U.S.C. 2604, 2607, and 2625(c).

### Source

Source: 49 FR 35018, Sept. 5, 1984, unless otherwise noted.

### Amendments

[86 FR 46128, Aug. 18, 2021]